- Home
- ACRE vs OM Comparison
ACRE vs OM Comparison
Compare ACRE & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- OM
- Stock Information
- Founded
- ACRE 2011
- OM 2003
- Country
- ACRE United States
- OM United States
- Employees
- ACRE N/A
- OM N/A
- Industry
- ACRE Real Estate Investment Trusts
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACRE Real Estate
- OM Health Care
- Exchange
- ACRE Nasdaq
- OM Nasdaq
- Market Cap
- ACRE 262.4M
- OM 247.1M
- IPO Year
- ACRE 2012
- OM 2020
- Fundamental
- Price
- ACRE $4.69
- OM $14.49
- Analyst Decision
- ACRE Hold
- OM Hold
- Analyst Count
- ACRE 5
- OM 1
- Target Price
- ACRE $4.75
- OM $22.00
- AVG Volume (30 Days)
- ACRE 404.5K
- OM 141.3K
- Earning Date
- ACRE 11-06-2025
- OM 11-05-2025
- Dividend Yield
- ACRE 12.82%
- OM N/A
- EPS Growth
- ACRE N/A
- OM N/A
- EPS
- ACRE N/A
- OM N/A
- Revenue
- ACRE $80,674,000.00
- OM $119,304,000.00
- Revenue This Year
- ACRE N/A
- OM $12.37
- Revenue Next Year
- ACRE N/A
- OM $10.52
- P/E Ratio
- ACRE N/A
- OM N/A
- Revenue Growth
- ACRE 58.54
- OM 2.47
- 52 Week Low
- ACRE $3.35
- OM $5.85
- 52 Week High
- ACRE $7.49
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- ACRE 49.05
- OM 51.70
- Support Level
- ACRE $4.45
- OM $13.59
- Resistance Level
- ACRE $4.83
- OM $15.08
- Average True Range (ATR)
- ACRE 0.10
- OM 0.79
- MACD
- ACRE -0.03
- OM 0.02
- Stochastic Oscillator
- ACRE 51.06
- OM 36.50
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.